Announcements Trials
Browse Landscape

Phase

Phase 2 106Phase 1 42Phase 1/2 38Phase 3 11Phase NA 3Phase EARLY_PHASE1 2Phase 4 1Phase 2/3 1

Status

Recruiting 1Not yet recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Waldenstrom Macroglobulinemia 1Lymphoma, Follicular 1Lymphoma 1

Interventions

Exercise 419Blood Specimen Collection 319Standard of Care 299Surveys and Questionnaires 242Radiosurgery 239Magnetic Resonance Spectroscopy 232Educational Status 223Methods 221Radiotherapy 216Early Intervention, Educational 200Interviews as Topic 142Practice Guidelines as Topic 141Biopsy 125Surgical Procedures, Operative 119Drug Therapy 119Acupuncture Therapy 119Control Groups 115Therapeutics 101Palliative Care 97Resistance Training 94Counseling 88Saline Solution 87Magnetic Resonance Imaging 84Cyclophosphamide 83Specimen Handling 73Cisplatin 73Radiofrequency Ablation 71Cognitive Behavioral Therapy 71Radiotherapy, Intensity-Modulated 68Colonoscopy 65

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase NA × OTHER × Bendamustine Hydrochloride × Clear all
NCT07126678 2025-08-17

Fixed-Duration Zanubrutinib, Bendamustine, and Obinutuzumab (ZBG) in Treatment-Naïve Advanced Stage Follicular Lymphoma

The First Affiliated Hospital with Nanjing Medical University

Phase NA Recruiting
15 enrolled
Lymphoid

Lymphoma, Follicular

NCT06942507 2025-04-30

BRZ-WM

Peking Union Medical College Hospital

Phase NA Not yet recruiting
104 enrolled
Lymphoid

Waldenstrom Macroglobulinemia

NCT05813132 2024-09-05

BeEAM Versus CEM in Lymphoma Patients as a Conditioning Regimen Before Autologous Hematopoietic Cell Transplantation

Damanhour University

Phase NA Completed
58 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡